Additionally, increasing evidence has demonstrated that EGFR-mutant NSCLC is not a single-oncogene disease [11, 12], and both EGFR-mutated and wild-type cancer cells can exist in the same tumor [13–15]. The gene discussed is EGFR; the disease is neoplasm.